|
 |
 |
 |
 |
 |
|
Let us help you find the right supplier for
Ophthalmic Drugs |
|
|
|
|
|
 Ophthalmic Drugs |
 Acyclovir | Betamethasone | Carboxy Methyl Cellulose |
| Chloramphenicol | Ciprofloxacin | Dexamethasone |
| Diclofenac | Gentamycin | Hydrocortisone |
| Ketorolac | Natamycin | Norfloxacin |
| Ofloxacin | Oxytetracycline |
|
Greenco Biologicals Private Limietd ( India) Company Profile: Engaged in production and supply of ophthalmic drugs, ent drugs, paediatric drugs, general formulations and gynae formulation. Contact Details:
Optima Health Care ( India) Company Profile: Manufacturer of all types of drugs like injectable and ophthalmic drugs. Contact Details:
Neiss Labs Ltd. ( India) Company Profile: Bulk exporters and manufacturers of pharmaceuticals drugs for infections in eye & ear like ofloxacin eye drops, timolol eye drops, ofloxacin ophthalmic solution, ciprofloxacin drops cipronis and timolol eye drops BP TIMONIS -0.25. Contact Details:
Serum Biotec Limited ( India) Company Profile: Exporting pharmaceutical drugs, blood plasma products, anti cancer medicines, antidepressants, antibiotic drugs, antidiabetic drugs, antihypertensive drugs, psychotropic drugs, infertility products, ophthalmic preparations and antiretroviral drugs. Contact Details:
Karan Health Care Private Limited ( India) Company Profile: Manufacturers and exporters of pain relief drug like chloramphenical maleate, amoxycillin, ampicillin, kargrip syrup, tetracycline hydrochloride ophthalmic ointment, chloramphenicol eye ointment, kargrip tablets and gentamicin sulfate cream. Contact Details:
Jupiter Manufacturing Works ( India) Company Profile: Manufacturing and exporting of hospital bed, hospital equipments, hospital ophthalmic tables, hospital stretcher trolleys, examination couches, operation tables, examination beds, drug trolleys, instrument trolleys and ambulance emergency trolleys etc. Contact Details:
|
 |
|
Drugs market for treating eye disorders at present is valued at US $ 9.6 billion having an average growth rate of 7.4 %, which is envisioned to further cross US $ 13.8 billion in 2011. This industry is experiencing a boom in terms of introduction of new ophthalmic drugs like dexamethasone, norfloxacin, gentamycin, ciprofloxacin, diclofenac, betamethasone, hydrocortisone, acyclovir, 
